Sterling Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$112K Buy
2,430
+1,847
+317% +$89K ﹤0.01% 1366
2026
Q2
$34.2K Buy
583
+74
+15% +$3.1K ﹤0.01% 1681
2026
Q1
$16.4K Buy
509
+2
+0.4% +$74 ﹤0.01% 2113
2025
Q4
$21.3K Buy
507
+317
+167% +$12.8K ﹤0.01% 2194
2025
Q3
$6.52K Buy
190
+1
+0.5% +$29 ﹤0.01% 2690
2025
Q2
$5.11K Sell
189
-1,155
-86% -$33.5K ﹤0.01% 2502
2025
Q1
$39.8K Sell
1,344
-1,077
-44% -$41.1K ﹤0.01% 1478
2024
Q4
$95.9K Buy
2,421
+2,155
+810% +$81.6K ﹤0.01% 1444
2024
Q3
$9.06K Buy
+266
New +$7.48K ﹤0.01% 1589

Other funds holding VCYT

Sterling Capital Management's VCYT Position: Q3 2026 in Review

Sterling Capital Management increased its Veracyte (VCYT) stake by 317% in Q3 2026, buying an estimated $89K and bringing the position to 2,430 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #1366.

Sterling Capital Management first reported a position in VCYT in Q3 2024 and has held it in 9 quarters since. 201 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • Sterling Capital Management held 2,430 shares of Veracyte worth $112K as of Q3 2026.
  • Sterling Capital Management bought 1,847 Veracyte shares in Q3 2026, an estimated $89K.
  • Veracyte made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #1366 holding.
  • Sterling Capital Management first reported a position in Veracyte in Q3 2024 and has held it in 9 quarters since.
  • 201 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.